The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

The startup will also use its generative AI technology to optimize manufacturing of the gene therapy, leveraging data that MeiraGTx has amassed over the course of nearly a decade developing its ...

artificial intelligence (AI) has been quietly improving the sector for years, from candidate prioritization in drug discovery to adverse event triage in clinical trials. Still, there are plenty of ...

Spatial transcriptomics is a cutting-edge technique that characterizes gene expression within sections of tissue, such as ...

AI researchers are celebrating a medical breakthrough: a new AI algorithm developed by a team of US researchers can detect ...

Traditional methods for identifying therapeutic gene targets, crucial for personalized medicine, are expensive and time-consuming. While artificial intelligence (AI), particularly deep learning ...

Artificial intelligence company Hologen AI has committed up to $430 million as part of a multifaceted agreement to help take MeiraGTx’s Parkinson’s disease gene therapy all the way to market.

BostonGene, a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, today announces it was named a Fierce Life Sciences Innovation Awards winner by ...

“The first wave of CRISPR therapies has focused on a small number of monogenic diseases caused by single-gene mutations. By bringing together AWS’s powerful cloud computing and AI solutions ...